PORTLAND, OR -- (MARKET WIRE) -- February 16, 2007 -- A high-dose activated vitamin D pill combined with docetaxel, a chemotherapy drug, extends the lives of men with advanced prostate cancer. And, there was no increase in toxic side effects with the combination of drugs as compared with taking docetaxel alone, according to a study published in the Feb. 20 issue of the Journal of Clinical Oncology by Oregon Health & Science University Cancer Institute principal investigator Tomasz M. Beer, M.D., national leader of the clinical trial.
